RxDoctor Payments Data

Sarita Nori, MD

Dermatology · Milford, MANPI 1891755443

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Eli Lilly at 31.7% of the total. Among dermatology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$85,760in general payments, 2019–2025

Across 394 payments — averaging $217.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$27K
  • Sun Pharmaceutical Industries Inc.$23K
  • Incyte Corporation$14K
  • Regeneron$6K
  • Sanofi$5K
  • Pfizer$2K
  • plus $10K from 24 others

What the payments were for

  • Consulting fees$23,93828%
  • Speaking & faculty fees$49,35458%
  • Travel & lodging$2,4163%
  • Food & beverage$9,59111%
  • Education$4611%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$85,760 in reported general payments places this provider in the 90th percentile of 552 dermatology providers in Massachusetts.

See all dermatology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$128,977
Medicare patients
505
Services billed
2,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab39$147,247
Tacrolimus59$4,915
Betamethasone Dipropionate97$4,019
Calcipotriene12$3,779
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc52$3,258
Metronidazole47$1,814
Fluorouracil40$1,774
Triamcinolone Acetonide172$1,598
Ketoconazole120$1,547
Dutasteride28$1,333
Mometasone Furoate38$1,231
Clobetasol Propionate18$1,231
Clindamycin Phosphate29$884
Imiquimod33$852
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip27$746

Paid to pharmacies, not to this prescriber.

Other dermatology in Milford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →